Skip to main content
Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
126.73
-1.13 (-0.88%)
At close: Jul 26, 2024, 4:00 PM
126.90
+0.17 (0.13%)
After-hours: Jul 26, 2024, 7:19 PM EDT

Novo Nordisk Revenue

Novo Nordisk had revenue of 65.35B DKK in the quarter ending March 31, 2024, with 22.45% growth. This brings the company's revenue in the last twelve months to 244.24B, up 29.72% year-over-year. In the year 2023, Novo Nordisk had annual revenue of 232.26B with 31.26% growth.

Revenue (ttm)
244.24B DKK
Revenue Growth
+29.72%
P/S Ratio
16.28
Revenue / Employee
3,797,369 DKK
Employees
64,319
Market Cap
575.53B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019122.02B10.19B9.11%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings

NVO News

More News